Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $7,889 | 2 | 79.3% |
| Food and Beverage | $1,965 | 104 | 19.7% |
| Education | $99.00 | 1 | 1.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $7,889 | 6 | $0 (2020) |
| Astellas Pharma US Inc | $431.37 | 23 | $0 (2021) |
| Janssen Biotech, Inc. | $303.35 | 23 | $0 (2024) |
| Olympus America Inc. | $169.94 | 2 | $0 (2023) |
| NeoTract Inc. | $120.91 | 1 | $0 (2018) |
| Sumitomo Pharma America, Inc. | $116.41 | 7 | $0 (2024) |
| 180 Medical, Inc. | $115.27 | 5 | $0 (2021) |
| Myovant Sciences Inc. | $80.18 | 4 | $0 (2022) |
| Amgen Inc. | $79.84 | 4 | $0 (2019) |
| UROGEN PHARMA, INC. | $65.56 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $234.54 | 11 | Janssen Biotech, Inc. ($57.82) |
| 2023 | $248.05 | 13 | Sumitomo Pharma America, Inc. ($100.40) |
| 2022 | $262.48 | 7 | Olympus America Inc. ($150.00) |
| 2021 | $302.74 | 13 | Astellas Pharma US Inc ($134.44) |
| 2020 | $41.10 | 4 | Endo Pharmaceuticals Inc. ($14.44) |
| 2019 | $277.25 | 18 | Astellas Pharma US Inc ($67.43) |
| 2018 | $529.33 | 32 | Janssen Biotech, Inc. ($180.66) |
| 2017 | $8,057 | 13 | Innovative Medical Technologies, LLC ($7,889) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/05/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $42.00 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 04/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: HORMONE THERAPY | ||||||
| 03/20/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/13/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: UROLOGY | ||||||
| 03/05/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Oncology | ||||||
| 02/28/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: UROTHELIAL CANCER | ||||||
| 02/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Trevena, Inc. | OLINVYK (Drug) | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: Pain Management | ||||||
| 01/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Oncology | ||||||
| 12/13/2023 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Diagnostic Imaging | ||||||
| 12/05/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Urology | ||||||
| 11/27/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Urology | ||||||
| 08/16/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: HORMONE THERAPY | ||||||
| 07/07/2023 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Urology Gynecology | ||||||
| 07/07/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2023 | ConvaTec Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: CONTINENCE CARE | ||||||
| 06/08/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: HORMONE THERAPY | ||||||
| 04/19/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: UROLOGY | ||||||
| 03/01/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/27/2023 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $36.65 | General |
| Category: Oncology | ||||||
| 01/04/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: HORMONE THERAPY | ||||||
| 01/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Urology | ||||||
| 12/07/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,507 | 3,594 | $479,271 | $107,991 |
| 2022 | 25 | 1,659 | 4,588 | $465,767 | $113,647 |
| 2021 | 30 | 1,829 | 3,356 | $515,688 | $118,372 |
| 2020 | 20 | 1,544 | 3,072 | $276,270 | $68,399 |
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 418 | 496 | $90,918 | $27,519 | 30.3% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 89 | 549 | $99,520 | $24,845 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 170 | $47,547 | $14,908 | 31.4% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 15 | 20 | $74,677 | $9,224 | 12.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 89 | $16,402 | $4,127 | 25.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 39 | $11,914 | $3,909 | 32.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 58 | 65 | $26,150 | $3,660 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $14,208 | $3,513 | 24.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $10,838 | $3,076 | 28.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 124 | 136 | $9,475 | $2,451 | 25.9% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 65 | $9,056 | $2,186 | 24.1% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 25 | 28 | $14,727 | $1,977 | 13.4% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 59 | 98 | $7,196 | $1,706 | 23.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 157 | 183 | $5,894 | $1,537 | 26.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 11 | $12,310 | $884.44 | 7.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 101 | 116 | $18,027 | $777.97 | 4.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 15 | 16 | $3,995 | $730.08 | 18.3% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 11 | 18 | $1,734 | $455.22 | 26.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 58 | 65 | $465.32 | $221.65 | 47.6% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 13 | 1,300 | $2,600 | $150.61 | 5.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 36 | 39 | $466.75 | $85.80 | 18.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 13 | 13 | $1,152 | $46.42 | 4.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 416 | 508 | $78,740 | $28,636 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 162 | 205 | $46,740 | $17,309 | 37.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 14 | 120 | $77,400 | $16,730 | 21.6% |
About Dr. Richard Klump, M.D
Dr. Richard Klump, M.D is a Urology healthcare provider based in Gahanna, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114971512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Klump, M.D has received a total of $9,953 in payments from pharmaceutical and medical device companies, with $234.54 received in 2024. These payments were reported across 111 transactions from 32 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($7,889).
As a Medicare-enrolled provider, Klump has provided services to 6,539 Medicare beneficiaries, totaling 14,610 services with total Medicare billing of $408,408. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Gahanna, OH
- Active Since 05/20/2006
- Last Updated 02/13/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1114971512
Products in Payments
- MYRBETRIQ (Drug) $208.51
- Erleada (Drug) $205.51
- iTIND System (Device) $169.94
- ORGOVYX (Drug) $142.35
- UroLift (Device) $120.91
- Myrbetriq (Drug) $83.70
- Prolia (Biological) $79.84
- GEMTESA (Drug) $78.23
- XTANDI (Drug) $69.33
- JELMYTO (Drug) $65.56
- JEVTANA (Drug) $62.25
- ERLEADA (Drug) $57.82
- PROVENGE (Drug) $53.97
- UROLIFT (Device) $42.00
- ZYTIGA (Drug) $40.02
- SPEEDICATH (Device) $35.25
- CAMCEVI (Drug) $31.98
- XIAFLEX (Biological) $30.54
- BOTOX (Biological) $30.42
- GENTLECATH (Device) $26.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Gahanna
Dr. Benjamin Martin, Md, MD
Urology — Payments: $255,155
Dr. Jeffrey Carey, M.d, M.D
Urology — Payments: $17,458
Dr. Rashmi Patel, M.d, M.D
Urology — Payments: $14,054
Dr. Scott Barkin, D.o, D.O
Urology — Payments: $10,715
Dr. Linda Osborne, D.o, D.O
Urology — Payments: $10,211
Mr. Andy Cho, M.d, M.D
Urology — Payments: $10,156